Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1981
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1987 1
1989 1
1990 2
1991 6
1992 2
1993 1
1994 3
1995 2
1996 6
1997 7
1998 11
1999 2
2000 9
2001 7
2002 5
2003 15
2004 13
2005 25
2006 20
2007 10
2008 24
2009 32
2010 43
2011 55
2012 56
2013 83
2014 62
2015 73
2016 82
2017 97
2018 92
2019 117
2020 153
2021 168
2022 239
2023 213
2024 236
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

1,800 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19 vaccine development: milestones, lessons and prospects.
Li M, Wang H, Tian L, Pang Z, Yang Q, Huang T, Fan J, Song L, Tong Y, Fan H. Li M, et al. Among authors: pang z. Signal Transduct Target Ther. 2022 May 3;7(1):146. doi: 10.1038/s41392-022-00996-y. Signal Transduct Target Ther. 2022. PMID: 35504917 Free PMC article. Review.
Phosphorylation of pyruvate dehydrogenase inversely associates with neuronal activity.
Yang D, Wang Y, Qi T, Zhang X, Shen L, Ma J, Pang Z, Lal NK, McClatchy DB, Seradj SH, Leung VH, Wang K, Xie Y, Polli FS, Maximov A, Gonzalez OC, de Lecea L, Cline HT, Augustine V, Yates JR 3rd, Ye L. Yang D, et al. Among authors: pang z. Neuron. 2024 Mar 20;112(6):959-971.e8. doi: 10.1016/j.neuron.2023.12.015. Epub 2024 Jan 23. Neuron. 2024. PMID: 38266644 Free article.
Vagal sensory neurons mediate the Bezold-Jarisch reflex and induce syncope.
Lovelace JW, Ma J, Yadav S, Chhabria K, Shen H, Pang Z, Qi T, Sehgal R, Zhang Y, Bali T, Vaissiere T, Tan S, Liu Y, Rumbaugh G, Ye L, Kleinfeld D, Stringer C, Augustine V. Lovelace JW, et al. Among authors: pang z. Nature. 2023 Nov;623(7986):387-396. doi: 10.1038/s41586-023-06680-7. Epub 2023 Nov 1. Nature. 2023. PMID: 37914931 Free PMC article.
Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma: The CAP 03 Phase 2 Nonrandomized Clinical Trial.
Mao L, Lian B, Li C, Bai X, Zhou L, Cui C, Chi Z, Sheng X, Wang X, Tang B, Yan X, Li S, Kong Y, Dai J, Wei X, Li J, Duan R, Xu H, Wu X, Yang Y, Cheng F, Zhang C, Xia F, Pang Z, Guo J, Si L. Mao L, et al. Among authors: pang z. JAMA Oncol. 2023 Aug 1;9(8):1099-1107. doi: 10.1001/jamaoncol.2023.1363. JAMA Oncol. 2023. PMID: 37261804 Free PMC article. Clinical Trial.
1,800 results